First Analysis Upgrades Anika Therapeutics (ANIk) to Strong Buy
Tweet Send to a Friend
First Analysis analyst Tracy Marshbanks upgraded Anika Therapeutics (NASDAQ: ANIk) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


